Skip to main content
Equibles
BPTH logo

BPTH · Bio-Path Holdings, Inc. · Webcasts, Transcripts & Audio

Track BPTH — free

Use BPTH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BPTH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.13 -0.08 (-38.10%) At close · Feb 19 Q3 2024 earnings call transcript
Rebalance outlook locked
Going-concern doubt — flagged May 20, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company’s available cash and cash equivalents of $0.1 million at March 31, 2026 will not be sufficient to fund liquidity and capital expenditure requirements for the next 12 months from the date of issuance of these consolidated financial statements. Therefore, substantial doubt exists about the Company’s ability to continue as a going concern.”
View the 10-Q filed May 20, 2026
Market Cap
$1.51M
Shares
50.30M
Volume · Feb 19 1.56M Avg daily vol (3M) 2.45M

Bio-Path Holdings, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Bio-Path Holdings, Inc. (BPTH), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY24 · Q3
2024-11-15
Bio-Path Holdings, Inc. (BPTH) Q3 2024 Earnings Call Transcript
Confident tone Prexigebersen (BP1001) in AML BP1002 in refractory/relapsed AML BP1003 (STAT3) and IND-enabling work
Diluted EPS
$-0.70
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-15
Bio-Path Holdings, Inc. (BPTH) Q2 2024 Earnings Call Transcript
Confident tone Prexigebersen (lead AML program) BP1002 (Bcl-2 / venetoclax-resistant AML) BP1003 (STAT3)
Diluted EPS
$-1.16
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-15
Bio-Path Holdings, Inc. (BPTH) Q1 2024 Earnings Call Transcript
Confident tone Prexigebersen (Lead AML Product Candidate) BP1002 (Bcl-2 Targeted Program) BP1003 STAT3 Program
Diluted EPS
$-4.88
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-08
Bio-Path Holdings, Inc. (BPTH) Q4 2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-15
Bio-Path Holdings, Inc. (BPTH) Q3 2023 Earnings Call
Diluted EPS
$-6.36
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-15
Bio-Path Holdings, Inc. (BPTH) Q2 2023 Earnings Call
Diluted EPS
$-10.64
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-12
Bio-Path Holdings, Inc. (BPTH) Q1 2023 Earnings Call
Diluted EPS
$-13.25
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-31
Bio-Path Holdings, Inc. (BPTH) Q4 2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-15
Bio-Path Holdings, Inc. (BPTH) Q3 2022 Earnings Call
Diluted EPS
$-9.80
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-16
Bio-Path Holdings, Inc. (BPTH) Q2 2022 Earnings Call
Diluted EPS
$-8.40
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-17
Bio-Path Holdings, Inc. (BPTH) Q1 2022 Earnings Call
Diluted EPS
$-9.40
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-04
Bio-Path Holdings, Inc. (BPTH) Q4 2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Bio-Path Holdings, Inc. (BPTH) Q3 2021 Earnings Call
Diluted EPS
$-5.80
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-13
Bio-Path Holdings, Inc. (BPTH) Q2 2021 Earnings Call
Diluted EPS
$-5.20
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-14
Bio-Path Holdings, Inc. (BPTH) Q1 2021 Earnings Call
Diluted EPS
$-8.60
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-10
Bio-Path Holdings, Inc. (BPTH) Q4 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-13
Bio-Path Holdings, Inc. (BPTH) Q3 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-14
Bio-Path Holdings, Inc. (BPTH) Q2 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-15
Bio-Path Holdings, Inc. (BPTH) Q1 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-10
Bio-Path Holdings, Inc. (BPTH) Q4 2019 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–20 of 20 webcasts
Key facts CIK 1133818 CUSIP 09057N409 Visit website Investor relations